A bill to amend the Controlled Substances Act to require the Attorney General to make procurement quotas for opioid analgesics publicly available, and for other purposes.

United States115th CongressS-1882Senate
Updated: Sep 28, 2017

Summary

Opioid Quota Openness, Transparency, and Awareness Act of 2017 or the Opioid QuOTA Act This bill amends the Controlled Substances Act to require the Drug Enforcement Administration (DEA) to publish on its website certain information with respect to a registered manufacturer’s opioid procurement quota. It defines the term "opioid procurement quota" as a quota established by the DEA for the quantity of opioid analgesics that a registered manufacturer may procure.

Bill texts

Available versions
Introduced (Senate)View official text

1 version available

All available records shown.

Timeline

  1. Read twice and referred to the Committee on the Judiciary.

    Senate

  2. Introduced in Senate

All available records shown.